AES
41
2
DVN
29
4
BMY
61
-3
SRE
66
-3
AVY
53
2
UPS
50
9
WMB
68
-2
DFS
67
-3
DRI
56
2
EXR
59
4
HCP
70
-4
XEL
65
-2
PFG
50
-2
HPE
70
2
REGN
42
-2
HSY
43
3
DD
61
4
HRL
30
-3
CI
52
-7
SHW
70
2
AES
41
2
DVN
29
4
BMY
61
-3
SRE
66
-3
AVY
53
2
UPS
50
9
WMB
68
-2
DFS
67
-3
DRI
56
2
EXR
59
4
HCP
70
-4
XEL
65
-2
PFG
50
-2
HPE
70
2
REGN
42
-2
HSY
43
3
DD
61
4
HRL
30
-3
CI
52
-7
SHW
70
2
Financhill
Back

Elite Pharmaceuticals Quote, Financials, Valuation and Earnings

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.
Sell
47

ELTP
Elite Pharmaceuticals

Last Price:
0.54
Seasonality Move:
10.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Elite Pharmaceuticals Price Quote

$0.54
-0.04 (-6.1%)
(Updated: November 14, 2024 at 11:35 AM ET)

Elite Pharmaceuticals Key Stats

Sell
47
Elite Pharmaceuticals (ELTP) is a Sell
Day range:
$0.56 - $0.59
52-week range:
$0.11 - $0.75
Dividend yield:
0%
P/E ratio:
28.01
P/S ratio:
8.75
P/B ratio:
10.27%
Volume:
2.1M
Avg. volume:
4M
1-year change:
399.65%
Market cap:
$598.3M
Revenue:
$56.6M
EPS:
$0.01

How Much Does Elite Pharmaceuticals Make?

Is Elite Pharmaceuticals Growing As A Company?

  • What Is Elite Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.09%
  • What Is Elite Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.49%

Elite Pharmaceuticals Stock Price Performance

What Is Elite Pharmaceuticals 52-Week High & Low?

Elite Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Elite Pharmaceuticals?

Is Elite Pharmaceuticals Cash Flow Positive?

  • What Is ELTP Cash Flow From Operations?
    Cash flow from operations (TTM) is $2.6M
  • What Is Elite Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$746.5K
  • What Is Elite Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.5M

Elite Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ELTP return on invested capital is 35.5%
  • What Is Elite Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 26.94%
  • What Is ELTP Return On Equity?
    ROE is a measure of profitability and is 41.23%

Elite Pharmaceuticals Earnings Date & Stock Price

Elite Pharmaceuticals Competitors

Elite Pharmaceuticals Dividend Yield

Elite Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: -49.16% 0%
Revenue: 109.39% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.00
Upside from Last Price: 595.53%

Major Shareholders

  • How many ELTP shares are owned by institutional investors?
    0 ELTP shares are owned by institutional investors
  • How many ELTP shares are owned by insiders?
    0 ELTP shares are owned by insiders